Literature DB >> 16563896

Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus.

Gautham Ravipati1, Wilbert S Aronow, Chul Ahn, Kumbar Sujata, Leonardo N Saulle, Melvin B Weiss.   

Abstract

Coronary angiography was performed in 152 men and 163 women with diabetes mellitus (mean age 55 +/- 8 years) because of chest pain. The mean hemoglobin A(1c) level was 6.66 +/- 0.58% in 132 patients with 0-vessel coronary artery disease (CAD), 8.00 +/- 0.84% in 40 patients with 1-vessel CAD, 8.83 +/- 1.45% in 76 patients with 2-vessel CAD, and 10.40 +/- 2.28% in 67 patients with 3- or 4-vessel CAD. There was a significant increasing trend of hemoglobin A(1c) levels over the increasing number of vessels with CAD (p <0.0001).

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16563896     DOI： 10.1016/j.amjcard.2005.10.039

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  16 in total

1.  Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.

Authors:  Alexander C Fanaroff; Stefan K James; Giora Weisz; Kristi Prather; Kevin J Anstrom; Daniel B Mark; Ori Ben-Yehuda; Karen P Alexander; Gregg W Stone; E Magnus Ohman
Journal:  J Am Coll Cardiol       Date:  2017-05-09       Impact factor: 24.094

2.  Treatment of systemic hypertension.

Authors:  Wilbert S Aronow
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

3.  Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study.

Authors:  Jorge Escobedo; Jamal S Rana; Manuel S Lombardero; Stewart G Albert; Andrew M Davis; Frank P Kennedy; Arshag D Mooradian; David G Robertson; V S Srinivas; Suzanne S P Gebhart
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

4.  Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients.

Authors:  Prabhavathi K; Kirthana Kunikullaya U; Jaisri Goturu
Journal:  J Clin Diagn Res       Date:  2014-02-03

5.  The association between C-reactive protein levels and insulin therapy in obese vs nonobese veterans with type 2 diabetes mellitus.

Authors:  Sameed Ahmed M Khatana; Tracey H Taveira; Andrea G Dooley; Wen-Chih Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

6.  Evaluation of salusin-α and salusin-β levels in patients with type 2 diabetes mellitus and determination of the impact of severity of hyperglycemia on salusin levels.

Authors:  Derya Argun; Ferit Argun; Betul Borku Uysal
Journal:  Ir J Med Sci       Date:  2021-06-09       Impact factor: 1.568

7.  Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina.

Authors:  Li-Feng Hong; Xiao-Lin Li; Yuan-Lin Guo; Song-Hui Luo; Cheng-Gang Zhu; Ping Qing; Rui-Xia Xu; Na-Qiong Wu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2014-05-29       Impact factor: 3.876

8.  Relationship between HgbA1c and myocardial blood flow reserve in patients with type 2 diabetes mellitus: noninvasive assessment using real-time myocardial perfusion echocardiography.

Authors:  Runqing Huang; Sahar S Abdelmoneim; Lara F Nhola; Sharon L Mulvagh
Journal:  J Diabetes Res       Date:  2014-07-02       Impact factor: 4.011

9.  Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus.

Authors:  Akram Shmendi; Fraser Pirie; Datshana P Naidoo; Boikhutso Tlou; Wilfred Pilloy; Ayesha A Motala
Journal:  Diabetes Metab Syndr Obes       Date:  2014-11-14       Impact factor: 3.168

10.  Elevated hemoglobin A1c Is Associated with Carotid Plaque Vulnerability: Novel Findings from Magnetic Resonance Imaging Study in Hypertensive Stroke Patients.

Authors:  Beibei Sun; Huilin Zhao; Xiaosheng Liu; Qing Lu; Xihai Zhao; Jun Pu; Jianrong Xu
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.